Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 18von Hippel-Lindau Disease 1Recurrence 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumor Grade 2 1Neuroblastoma 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lung Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoid Tumor 1Adenoma, Islet Cell 1

Interventions

Single Photon Emission Computed Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neuroendocrine Tumor Grade 2 × NET × Clear all
NCT05111509 2025-07-14

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumor Grade 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡